Hematological Malignancies In Children, Adolescents And Young Adults (With Cd-rom)

General Considerations: Epidemiology of Hematological Malignancies of Childhood, Adolescents and Young Adults (CAYA); The WHO Classification of Hematological Malignancies; Special Considerations in Infants and Adolescents; Pathobiology: Morphology and Immunophenotypic Diagnosis of Hematologic Malignancies in CAYA; Cytogenetics in CAYA with ALL and AML; Cytogenetics in CAYA with Lymphoma; Molecular Genetics in CAYA with Lymphoma; Pharmacogenetics and Drug Resistance; Minimal Residual Disease; Clinical Manifestations and Treatment: Childhood ALL; Adolescent and Young Adult ALL; Childhood, Adolescent and Young Adult Acute Myeloid Leukemias; Juvenile Myelomonocytic Leukemia in Children, Adolescents and Young Adults; Chronic Myeloid Leukemia and Myeloproliferative Neoplasms/MDS in Children, Adolescents and Young Adults; Childhood Non-Hodgkin Lymphoma; CAYA Hodgkin Lymphoma; Adolescent and Young Adult Non-Hodgkin Lymphoma; Immunodeficiency Associated Hematological Malignancies; Stem Cell Transplantation for CAYA with Hematological Malignancies; Antibody-Targeted Therapy for CAYA with Hematological Malignancies; Novel Therapeutics in Hematologic Malignancies; Adoptive Cellular and Gene Therapy; Supportive Care and Complications: Late Complications and Effects; Infectious Complications; Complementary and Alternative Medicine; Nursing Care; Psychosocial Considerations; Special Considerations in Under Resourced Countries; TLS and other Emergencies.